- Home
- AQB vs CNSP Comparison
AQB vs CNSP Comparison
Compare AQB & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AQB | CNSP |
|---|---|---|
| Founded | 1991 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3M | 3.8M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | AQB | CNSP |
|---|---|---|
| Price | $0.88 | $3.63 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 35.6K | ★ 77.5K |
| Earning Date | 03-26-2026 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.50 | $3.98 |
| 52 Week High | $2.95 | $114.00 |
Technical Indicators
Market Signals| Indicator | AQB | CNSP |
|---|---|---|
| Relative Strength Index (RSI) | 47.75 | 23.07 |
| Support Level | $0.78 | $5.76 |
| Resistance Level | $1.01 | $4.62 |
| Average True Range (ATR) | 0.08 | 0.41 |
| MACD | -0.01 | -0.20 |
| Stochastic Oscillator | 30.39 | 0.00 |
Price Performance
Historical ComparisonAbout AQB AquaBounty Technologies Inc.
AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.